Prevention and Management of the Post-Thrombotic Syndrome.

J Clin Med · 2020 · PMC7230648 · PMID 32230912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The long-term EINSTEIN follow-up ancillary study also showed a trend to decreased risk of PTS with rivaroxaban, but this was again not statistically significant (HR 0.76, (0.51–1.13)).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.